Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Celenova

Approved

STANDARD

Celenova

Ratnamani Healthcare Pvt. Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: e23d4ff8c6b624b3
Company: Ratnamani Healthcare Pvt. Ltd.
Type: Standard

Approval Details

Approval Id: e23d4ff8c6b624b3
Drug Approval Philippines Name: Celenova
Product Name: Celenova
Registration Number: DRP-12528
Brand Name: Celenova
Generic Name: Celecoxib
Dosage Form: Capsule
Dosage Strength: 200 mg
Manufacturer: Ratnamani Healthcare Pvt. Ltd.
Importer: Medinova Pharmaceutical Inc.
Distributor: Medinova Pharmaceutical Inc.
Issuance Date: 26 August 2022
Expiry Date: 26 August 2027
Pharmacologic Category: Non-Steroidal Anti-Inflammatory Drug (NSAID)
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

e23d4ff8c6b624b3

Type

Standard

Back to Philippines FDA Approvals

Celenova - Philippines FDA Drug Approval Details